Replies to post #17855 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Thanks for the update on Kevetrin Phase I data points. I'll be linking to this soon. ;)







In Reply to 'TheProgressive'
Partial quote:
Glad it still being put to use, here is a slightly more updated one with cohort start dates if youd like to use that, thanks umiak!

KEVETRIN PHASE 1 CLINICAL TRIAL DATA POINTS AND TIMELINE - REPOST FOR NEWER MEMBERS

With the trial underway, here is a chronological summary of phase 1 trial data points and measures:


Primary Outcome Measures:
Dose Limiting Toxicities (DLT) of Kevetrin. [ Time Frame: up to 4 weeks ]
Maximum Tolerated Dose (MTD) of Kevetrin [ Time Frame: up to 6 months ]


COHORT 1 -DAY 1 TO TAKE PLACE ON/AROUND, NOV 1ST, 2012 (WITHIN A FEW DAY WINDOW)


COHORT 2 - DAY 1 TO TAKE PLACE ON/AROUND , DEC 15TH, 2012 (WITHIN A FEW DAY WINDOW)

COHORT 3 - DAY 1 - TO BE DETERMINED